<DOC>
	<DOC>NCT01256710</DOC>
	<brief_summary>The purpose of the SJM International, Inc. sponsored "Trifecta™ Durability Study", is to evaluate the long-term durability of the Trifecta™ valve.</brief_summary>
	<brief_title>Trifecta Durability Study</brief_title>
	<detailed_description />
	<criteria>Patients implanted for less than 9 months, or candidate for implantation with a St Jude Medical Trifecta valve, as per current guidelines Patient requires aortic valve replacement. Patient is legal age in host country. Patients must be able and willing to provide written informed consent to participate in this investigation Patients must be willing and able to comply with all followup requirements Patients with contraindication for cardiac surgery Patients who are pregnant. Patient is unwilling to or has an inability that reduces his mobility in order to attend the required followup visits. Patient has active endocarditis Patient has had an acute preoperative neurological event defined as patient has not returned to baseline 30 days prior to the planned valve implantation surgery. Patient is undergoing renal dialysis. Patient has a documented history of substance abuse within one year of enrollment or is currently a prison inmate. Patient has a documented thrombus in left atrium or left ventricle. Patient had in the past mitral or tricuspid valve replacement. Patient needs mitral and/or tricuspid valve replacement. Patient has an Ejection Fraction &lt; 25% Patient had the Trifecta™ valve implanted as part of this study, but then had the device explanted Preoperative evaluation indicates other significant cardiovascular abnormalities such as aortic dissection or ventricular aneurysm. Patient has a life expectancy less than two years.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>